Literature DB >> 16135731

A prediction rule for clinical diagnosis of severe acute respiratory syndrome.

P L Ho1, P H Chau, P S F Yip, G C Ooi, P L Khong, J C Ho, P C Wong, C Ko, C Yan, K W Tsang.   

Abstract

A prospective study was undertaken to identify clinical, radiographical, haematological and biochemical profiles of severe acute respiratory syndrome (SARS) patients. A prediction rule, which demarcates low from high risk patients for SARS in an outbreak situation was developed. A total of 295 patients with unexplained respiratory illnesses, admitted to Queen Mary Hospital, Hong Kong SAR, China, in March to July 2003, were evaluated for clinical, radiological, haematological and alanine transaminase (ALT) data daily for 3 days after hospitalisation. In total, 44 cases were subsequently confirmed to have SARS by RT-PCR (68.2%) and serology (100%). The scoring system of attributing 11, 10, 3, 3 and 3 points to the presence of independent risk factors, namely: epidemiological link, radiographical deterioration, myalgia, lymphopenia and elevated ALT respectively, generated high and low-risk (total score 11-30 and 0-10, respectively) groups for SARS. The sensitivity and specificity of this prediction rule in positively identifying a SARS patient were 97.7 and 81.3%, respectively. The positive and negative predictive values were 47.8 and 99.5%, respectively. The prediction rule appears to be helpful in assessing suspected patients with severe acute respiratory syndrome at the bedside, and should be further validated in other severe acute respiratory syndrome cohorts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135731     DOI: 10.1183/09031936.05.1076704

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Clinical applications of molecular biology for infectious diseases.

Authors:  David J Speers
Journal:  Clin Biochem Rev       Date:  2006-02

2.  A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.

Authors:  Anjeanette Roberts; Damon Deming; Christopher D Paddock; Aaron Cheng; Boyd Yount; Leatrice Vogel; Brian D Herman; Tim Sheahan; Mark Heise; Gillian L Genrich; Sherif R Zaki; Ralph Baric; Kanta Subbarao
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

Review 3.  Emerging pathogens: challenges and successes of molecular diagnostics.

Authors:  Jianli Dong; Juan P Olano; Jere W McBride; David H Walker
Journal:  J Mol Diagn       Date:  2008-04-10       Impact factor: 5.568

4.  Imaging of COVID-19.

Authors:  Danielle Toussie; Nicholas Voutsinas; Michael Chung; Adam Bernheim
Journal:  Semin Roentgenol       Date:  2021-10-07       Impact factor: 0.800

5.  Comparison of confirmed COVID-19 with SARS and MERS cases - Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis.

Authors:  Ali Pormohammad; Saied Ghorbani; Alireza Khatami; Rana Farzi; Behzad Baradaran; Diana L Turner; Raymond J Turner; Nathan C Bahr; Juan-Pablo Idrovo
Journal:  Rev Med Virol       Date:  2020-06-05       Impact factor: 11.043

6.  Elevated plasma surfactant protein D (SP-D) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific IgG antibody in SARS patients.

Authors:  Y P Wu; Z H Liu; R Wei; S D Pan; N Y Mao; B Chen; J J Han; F S Zhang; U Holmskov; Z L Xia; P G de Groot; K B M Reid; W B Xu; G L Sorensen
Journal:  Scand J Immunol       Date:  2009-06       Impact factor: 3.487

7.  Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak.

Authors:  Yishan Wang; Hanyujie Kang; Xuefeng Liu; Zhaohui Tong
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

8.  Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization.

Authors:  N Lee; T H Rainer; M Ip; B Zee; M H Ng; G E Antonio; E Chan; G Lui; C S Cockram; J J Sung; D S Hui
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.